Constellium to Report Fourth Quarter and Full Year 2016 Results

AMSTERDAM, Feb. 28, 2017 /PRNewswire/ -- Constellium N.V. (NYSE and Euronext: CSTM) will host a conference call and webcast on Thursday, March 9, 2017 at 11:00 a.m. (Eastern Standard Time) to announce its fourth quarter and full year 2016 financial results. The press release will be sent the day before, after market closing.

The conference call will be hosted by Jean-Marc Germain, Chief Executive Officer, and Peter Matt, Executive Vice President and Chief Financial Officer.

Details of the conference call, webcast and accompanying presentation will be available on the Constellium Investor Relations page at:

The webcast can be accessed live at:

https://www.webcaster4.com/Webcast/Page/999/19894

To participate by telephone, please dial the following number and ask to be connected to the Constellium earnings call:

  • USA: 1 866 376 8056
  • France: 0 805 102 319
  • Germany: 0 800 589 5393
  • Switzerland: 0 800 246 787
  • United Kingdom: 0 800 279 9489
  • Other: 1 412 902 4221

An archived recording of the conference call will also be available at www.constellium.com for three weeks.

Constellium will be hosting its 2017 Analyst Day on March 22 at the New York Stock Exchange. To register or access the live broadcast, please contact investor-relations@constellium.com.

About Constellium
Constellium (NYSE and Euronext: CSTM) is a global sector leader that develops innovative, value added aluminium products for a broad scope of markets and applications, including aerospace, automotive and packaging. Constellium generated €5.2 billion of revenue in 2015.

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/constellium-to-report-fourth-quarter-and-full-year-2016-results-300414605.html

SOURCE Constellium N.V.

Related Stocks:
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.